- Issuer ticker
-
HEPA
- Reported as of
-
23 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
27 Oct 2026, 16:30:42 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ James G. Liddy
Filing notes and source
Key filing fact
James G. Liddy filed Form 4 for Hepion Pharmaceuticals, Inc. (HEPA) on 27 Oct 2026.
Key facts
- This page summarizes James G. Liddy's Form 4 filing for Hepion Pharmaceuticals, Inc. (HEPA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 27 Oct 2026, 16:30.
Change
- Previous filing in this sequence was filed on 21 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002082917
Primary reporting owner
Liddy James Gordon
- Relationship
-
Director
- Address
- C/O HEPION PHARMACEUTICALS, INC., 22 WEST ST., SUITE 1B, RED BANK
- Signature
- /s/ James G. Liddy
- Signature date
- 27 Oct 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HEPA
transaction
Derivative
Stock Options
Award
- Transaction value
- Shares
- +510,000
- Change %
- +171%
- Price
-
$0.000000*
- Shares after
- 809,000
- Date
- 23 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 510,000
- Exercise price
- $0.1400
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote